Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04737109
Title Neoadjuvant Androgen Deprivation, Darolutamide, and Ipatasertib in Men With Localized, High Risk Prostate Cancer
Acronym ADDItion
Recruitment Terminated
Gender male
Phase Phase Ib/II
Variant Requirements Yes
Sponsors David VanderWeele
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Northwestern University Feinberg School of Medicine Chicago Illinois 60611 United States Details
Indiana University Melvin and Bren Simon Comprehensive Cancer Center Indianapolis Indiana 46202 United States Details
Penn State Cancer Institute Hershey Pennsylvania 17033 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field